Laura Gault
Technik-/Wissenschafts-/F&E-Leiter bei SAGE THERAPEUTICS, INC.
Vermögen: 3 083 $ am 30.04.2024
Aktive Positionen von Laura Gault
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SAGE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.10.2022 | - |
Karriereverlauf von Laura Gault
Ehemalige bekannte Positionen von Laura Gault
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2019 | 01.11.2022 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.01.2017 | 01.03.2019 |
Ausbildung von Laura Gault
Case Western Reserve University | Doctorate Degree |
University of Pittsburgh | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SAGE THERAPEUTICS, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Private Unternehmen | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Laura Gault
- Erfahrung